NCT03638583 Alzheimer Prevention Trials (APT) Webstudy
| NCT ID | NCT03638583 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Alzheimer Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 200,000 participants |
| Start Date | 2017-12-20 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200,000 participants in total. It began in 2017-12-20 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the Alzheimer Prevention Trials (APT) Webstudy is to accelerate enrollment for Alzheimer's disease (AD) clinical trials by identifying and tracking individuals who may be at higher risk for developing AD dementia.
Eligibility Criteria
Inclusion Criteria: * male or female at least 50 years of age * no evidence of dementia * willing to participate in remote longitudinal cognitive testing and possible referral for biomarker assessment based on risk Exclusion Criteria: * N/A. Anyone can register for the APT Webstudy, however, only individuals identified using the risk algorithm will be referred for in-person biomarker assessments.
Contact & Investigator
Paul Aisen, MD
PRINCIPAL INVESTIGATOR
USC ATRI
Frequently Asked Questions
Who can join the NCT03638583 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03638583 currently recruiting?
Yes, NCT03638583 is actively recruiting participants. Contact the research team at info@aptwebstudy.org for enrollment information.
Where is the NCT03638583 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT03638583 clinical trial?
NCT03638583 is sponsored by University of Southern California. The principal investigator is Paul Aisen, MD at USC ATRI. The trial plans to enroll 200,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.